InfuSystem Holdings, Inc. (INFU)
INFUAMEXMedical/Dental Instruments
$14.79
+0.0700 (+0.48%) today
At the close, Nov 16, 4:00 PM ET. After hours $14.69 -0.81%
- Market cap
- $296.70m
- P/E
- 32.9
- EPS, last 4 quarters
- $0.4500
- Dividend yield
- –
- Day range
- $14.58 to $14.97
- 52-week range
- $7.29 to $15.47
- Average volume
- –
- Previous close
- $14.72
Analysts
2 coveringStrong Buy2 buy, 0 hold, 0 sell
Targets a year out average $17.75, +20.0% from here
Earnings
Next report
Dec 2025
+42.9%
Mar 2026
+25.0%
Jun 2026
+25.0%
Sep 2026
–
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $36.23m | $33.68m | $36.93m | $37.59m |
| Gross profit | $20.43m | $19.68m | $21.41m | $21.73m |
| Operating income | $3.71m | $1.59m | $4.15m | $4.75m |
| Net income | $2.04m | $1.02m | $3.23m | $3.16m |
Last four quarters: revenue $144.44m, margin 6.5%, free cash flow $13.27m
News
8 latest- InfuSystem (INFU) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- InfuSystem Holdings Consensus Price Target Increased by 11.39% to $19.12Fintel · 6 days ago
- InfuSystem Holdings, Inc. Reports Third Quarter 2026 Net Revenues of $37.6 millionFintel · Nov 5, 2026
- InfuSystem Holdings, Inc. Postpones Third Quarter 2026 Earnings ReleaseFintel · Nov 3, 2026
- Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5% RTTNews · Oct 6, 2026
- Biotech Stocks At 52-Week Highs - OMER +13%, TKNO +5%, BLFS, SDGR, INFU RTTNews · Sep 23, 2026
- InfuSystem (INFU) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 11, 2026
- Biotech Stocks At 52-Week Highs - UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS RTTNews · Aug 5, 2026
The company
InfuSystem Holdings, Inc. (NYSE American:INFU), is a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services , providing last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- AMEX
- Region
- North America
- Website
- infusystem.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.